Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.

How a new scheme for young people leaving care is tackling what was once a cliff-edge for this vulnerable group.

As scientists edge closer to new treatments for hair loss, Victoria Derbyshire examines what such breakthroughs could mean for women.

Women taking the drug, which is kinder on the body, tell the BBC it has given them their lives back.

Research suggests NHS trusts with higher empathy ratings also benefit financially and have improved staff wellbeing

Patients and staff fare better at hospitals that rank highly on empathy, research suggests, with institutions also benefiting financially by spending less on agency staff, locums and consultants.

The finding comes from the first study to rate NHS trusts in England according to an empathy score that is drawn from information on the organisation’s culture, leadership behaviour and practitioner empathy, among other factors.

Continue reading...

Lord Mann’s review prompts new training for health bosses and restrictions on political symbols on uniforms

The NHS is taking action to tackle antisemitism after a government-ordered report found that Jewish patients and staff face “routine ostracism” in the service.

Anti-Jewish hatred in the NHS means some patients hide their identity and staff “suffer in silence”, a review by Lord Mann, the government’s adviser on antisemitism, has found.

Continue reading...

Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years

Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant ovarian cancer to be approved for more than 20 years.

Ovarian is the 18th most common type of cancer globally, affecting more than 300,000 women a year. More than three-quarters of patients are diagnosed at an advanced stage, making it harder to treat.

Continue reading...